290 related articles for article (PubMed ID: 11074616)
1. Molecular cytogenetics of prostate cancer.
Nupponen NN; Visakorpi T
Microsc Res Tech; 2000 Dec; 51(5):456-63. PubMed ID: 11074616
[TBL] [Abstract][Full Text] [Related]
2. Genetic alterations in untreated metastases and androgen-independent prostate cancer detected by comparative genomic hybridization and allelotyping.
Cher ML; Bova GS; Moore DH; Small EJ; Carroll PR; Pin SS; Epstein JI; Isaacs WB; Jensen RH
Cancer Res; 1996 Jul; 56(13):3091-102. PubMed ID: 8674067
[TBL] [Abstract][Full Text] [Related]
3. Molecular genetics of prostate cancer.
Visakorpi T
Ann Chir Gynaecol; 1999; 88(1):11-6. PubMed ID: 10230676
[TBL] [Abstract][Full Text] [Related]
4. Distinct chromosomal aberrations of ampulla of Vater and pancreatic head cancers detected by laser capture microdissection and comparative genomic hybridization.
Chang MC; Chang YT; Tien YW; Sun CT; Wu MS; Lin JT
Oncol Rep; 2005 Oct; 14(4):867-72. PubMed ID: 16142344
[TBL] [Abstract][Full Text] [Related]
5. Genetic changes in primary and recurrent prostate cancer by comparative genomic hybridization.
Visakorpi T; Kallioniemi AH; Syvänen AC; Hyytinen ER; Karhu R; Tammela T; Isola JJ; Kallioniemi OP
Cancer Res; 1995 Jan; 55(2):342-7. PubMed ID: 7529134
[TBL] [Abstract][Full Text] [Related]
6. Chromosomal aberrations in prostate cancer xenografts detected by comparative genomic hybridization.
Laitinen S; Karhu R; Sawyers CL; Vessella RL; Visakorpi T
Genes Chromosomes Cancer; 2002 Sep; 35(1):66-73. PubMed ID: 12203791
[TBL] [Abstract][Full Text] [Related]
7. Genomic aberrations in carcinomas of the uterine corpus.
Micci F; Teixeira MR; Haugom L; Kristensen G; Abeler VM; Heim S
Genes Chromosomes Cancer; 2004 Jul; 40(3):229-46. PubMed ID: 15139002
[TBL] [Abstract][Full Text] [Related]
8. Chromosomal changes during development and progression of prostate adenocarcinomas.
Zitzelsberger H; Engert D; Walch A; Kulka U; Aubele M; Höfler H; Bauchinger M; Werner M
Br J Cancer; 2001 Jan; 84(2):202-8. PubMed ID: 11161378
[TBL] [Abstract][Full Text] [Related]
9. [Molecular pathology of prostate carcinoma. Academic playground or guide for diagnosis and therapy planning?].
Bubendorf L
Verh Dtsch Ges Pathol; 2004; 88():158-64. PubMed ID: 16892547
[TBL] [Abstract][Full Text] [Related]
10. Genetic aberrations in prostate carcinoma detected by comparative genomic hybridization and microsatellite analysis: association with progression and angiogenesis.
Strohmeyer DM; Berger AP; Moore DH; Bartsch G; Klocker H; Carroll PR; Loening SA; Jensen RH
Prostate; 2004 Apr; 59(1):43-58. PubMed ID: 14991865
[TBL] [Abstract][Full Text] [Related]
11. Genotypic analysis of esophageal squamous cell carcinoma by molecular cytogenetics and real-time quantitative polymerase chain reaction.
Yen CC; Chen YJ; Lu KH; Hsia JY; Chen JT; Hu CP; Chen PM; Liu JH; Chiou TJ; Wang WS; Yang MH; Chao TC; Lin CH
Int J Oncol; 2003 Oct; 23(4):871-81. PubMed ID: 12963965
[TBL] [Abstract][Full Text] [Related]
12. DNA sequence copy number aberrations in prostate cancers: a comparison of comparative genomic hybridization data between Japan and European countries.
Matsuda K; Matsuyama H; Hara T; Yoshihiro S; Oga A; Kawauchi S; Furuya T; Izumi H; Naito K; Sasaki K
Cancer Genet Cytogenet; 2004 Jul; 152(2):119-23. PubMed ID: 15262429
[TBL] [Abstract][Full Text] [Related]
13. Comprehensive molecular cytogenetic characterization of cervical cancer cell lines.
Harris CP; Lu XY; Narayan G; Singh B; Murty VV; Rao PH
Genes Chromosomes Cancer; 2003 Mar; 36(3):233-41. PubMed ID: 12557223
[TBL] [Abstract][Full Text] [Related]
14. Molecular cytogenetics of primary breast cancer by CGH.
Tirkkonen M; Tanner M; Karhu R; Kallioniemi A; Isola J; Kallioniemi OP
Genes Chromosomes Cancer; 1998 Mar; 21(3):177-84. PubMed ID: 9523192
[TBL] [Abstract][Full Text] [Related]
15. Clinical significance of alterations of chromosome 8 detected by fluorescence in situ hybridization analysis in pathologic organ-confined prostate cancer.
Tsuchiya N; Slezak JM; Lieber MM; Bergstralh EJ; Jenkins RB
Genes Chromosomes Cancer; 2002 Aug; 34(4):363-71. PubMed ID: 12112525
[TBL] [Abstract][Full Text] [Related]
16. Comparative genomic hybridization of hepatocellular carcinoma: correlation with fluorescence in situ hybridization in paraffin-embedded tissue.
Rao UN; Gollin SM; Beaves S; Cieply K; Nalesnik M; Michalopoulos GK
Mol Diagn; 2001 Mar; 6(1):27-37. PubMed ID: 11257209
[TBL] [Abstract][Full Text] [Related]
17. Genomic alterations in lung adenocarcinomas detected by multicolor fluorescence in situ hybridization and comparative genomic hybridization.
Shen H; Zhu Y; Wu YJ; Qiu HR; Shu YQ
Cancer Genet Cytogenet; 2008 Mar; 181(2):100-7. PubMed ID: 18295661
[TBL] [Abstract][Full Text] [Related]
18. Multiple abnormalities detected by dye reversal genomic microarrays in prostate cancer: a much greater sensitivity than conventional cytogenetics.
Pettus JA; Cowley BC; Maxwell T; Milash B; Stephenson RA; Rohr LR; Hoff C; Brothman AR
Cancer Genet Cytogenet; 2004 Oct; 154(2):110-8. PubMed ID: 15474145
[TBL] [Abstract][Full Text] [Related]
19. Chromosomal aberrations in prostate cancer.
Saramaki O; Visakorpi T
Front Biosci; 2007 May; 12():3287-301. PubMed ID: 17485299
[TBL] [Abstract][Full Text] [Related]
20. Cytogenetic aberrations in primary and recurrent fibrolamellar hepatocellular carcinoma detected by comparative genomic hybridization.
Wilkens L; Bredt M; Flemming P; Kubicka S; Klempnauer J; Kreipe H
Am J Clin Pathol; 2000 Dec; 114(6):867-74. PubMed ID: 11338475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
